Chronic active Epstein-Barr virus disease

From IDWiki
Revision as of 01:34, 16 October 2020 by Aidan (talk | contribs)

Background

  • Life-threatening inflammatory disorder and lymphoid neoplasm caused by infection with Epstein-Barr virus involving NK and T cells

Pathophysiology

  • EBV infection involving B, T, and/or NK cells

Epidemiology

  • Most cases reported in Japan and East Asia
  • In the Americas, more common in Indigenous populations
  • However, can occur in people of all ethnicities

Clinical Manifestations

Related Disorders

Severe mosquito bite allergy

  • A severe hypersensitivity reaction to saliva in the bite of Aedes albopictus mosquitoes
  • Characterized by local skin inflammation followed by high fever, lymphadenopathy, and liver dysfunction
  • The bite can ulcerate and scar
  • Resoves within a month

Hydroa vacciniforme

  • Characterized by light-induced vesicles
  • Can also involve systemic inflammation

Diagnostic Criteria

  • Sustained or recurrent IM‐like symptoms for greater than 3 months
    • Symptoms include fever, lymphadenopathy, and hepatosplenomegaly, and possibly other symptoms
  • Elevated EBV genome load in the peripheral blood (>102.5 copies/µg DNA)
  • EBV infection of T or NK cells in the affected tissues or peripheral blood
  • Exclusion of other possible diagnoses including the following:
    • Primary EBV infection (infectious mononucleosis)
    • Primary immunodeficiencies
    • HIV
    • Iatrogenic immunosuppression
    • Autoimmune or collagen vascular diseases
    • Other malignant lymphoma (classic Hodgkin lymphoma, extranodal NK/T cell lymphoma, including nasal type, peripheral T cell lymphomas, and aggressive NK‐cell leukemia)

Diagnosis

  • Can follow a series of stepwise diagnostic tests:
    • Anti-EBV antibodies demonstrating anti-VCA-IgG (necessary for diagnosis), anti-EA-IgG, and anti-VCA-IgA or anti-EA-IgA antibodies
      • Anti-EBNA antibodies may be negative
    • EBV DNA viral load ≥102.5 copies/μg DNA
    • Detection of EBV infection of T or NK cells in affected tissues or peripheral blood

Management

Further Reading

  • Advances in the Study of Chronic Active Epstein-Barr Virus Infection: Clinical Features Under the 2016 WHO Classification and Mechanisms of Development. Front Pediatr. 2019;7:14. doi: 10.3389/fped.2019.00014